Literature DB >> 22234492

Association of amyotrophic lateral sclerosis and Behcet's disease: is there a relationship? A multi-national case series.

Hela Mrabet1, Afshin Borhani-Haghighi, Emel Koseoglu, Melike Mutlu, Recep Baydemir, Shahriar Nafissi, Slim Eschebbi, Emel Delibas, Shahdokht Samangooie, Fatih Yetkin, Amel Mrabet, Yesim Parman, Seyed Taghi Heydari, Gulsen Akman-Demir.   

Abstract

Neurological involvement may be seen in 5-30% of the patients with Behcet's disease (BD). Occasionally, parenchymal neurological involvement in BD can present as a spinal cord syndrome. However, motor neuron disease-like presentation is extremely uncommon. Here we are reporting five patients (all male; median age, 38) fulfilling both International Study Group criteria for BD and El Escorial criteria for amyotrophic lateral sclerosis (ALS). These patients were identified by a questionnaire sent to the members of the Neuro-Behcet Study Group of the International Study Group for BD. Three out of five patients had only motor presentations. In two patients, sensory and urinary manifestations were present as well. Spinal cord MRIs were normal in all, and brain MRIs were normal in four patients; one patient had nonspecific white matter changes. Two patients passed away 1-3 years after diagnosis of ALS, and two patients were lost to follow-up 3 and 11 years after admission; one patient is still alive 3 years after onset. The patients that are presented here might represent a rare form of neurological involvement in BD as well as sole coincidence. Larger prospective series are needed to further answer this issue.

Entities:  

Mesh:

Year:  2012        PMID: 22234492     DOI: 10.1007/s10067-011-1923-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

1.  A case of recurrent myositis as the main manifestation of Behçet disease.

Authors:  Takeshi Ogose; Wataru Tamaki; Kumi Shinahara; Masaya Kaneko; Yoshifumi Wakata; Keishi Naruse
Journal:  Pediatr Int       Date:  2010-04       Impact factor: 1.524

2.  Neurological manifestations of Behçet's disease.

Authors:  Afshin Borhani-Haghighi; Shahdokht Samangooie; Nahid Ashjazadeh; Alireza Nikseresht; Abdolhamid Shariat; Gholamali Yousefipour; Anahid Safari
Journal:  Saudi Med J       Date:  2006-10       Impact factor: 1.484

3.  Familial risks for amyotrophic lateral sclerosis and autoimmune diseases.

Authors:  Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Neurogenetics       Date:  2008-12-17       Impact factor: 2.660

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 5.  Inflammation in ALS and SMA: sorting out the good from the evil.

Authors:  Dimitra Papadimitriou; Virginia Le Verche; Arnaud Jacquier; Burcin Ikiz; Serge Przedborski; Diane B Re
Journal:  Neurobiol Dis       Date:  2009-10-13       Impact factor: 5.996

6.  Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.

Authors:  T Sekizawa; H Openshaw; K Ohbo; K Sugamura; Y Itoyama; J C Niland
Journal:  J Neurol Sci       Date:  1998-02-05       Impact factor: 3.181

7.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group.

Authors:  G Akman-Demir; P Serdaroglu; B Tasçi
Journal:  Brain       Date:  1999-11       Impact factor: 13.501

8.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

9.  [Behçet's disease in Tunisia. Clinical study of 519 cases].

Authors:  S B'chir Hamzaoui; A Harmel; K Bouslama; M Abdallah; M Ennafaa; S M'rad; M Ben Dridi
Journal:  Rev Med Interne       Date:  2006-08-18       Impact factor: 0.728

Review 10.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

View more
  3 in total

Review 1.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

2.  Spectrum of Genetic Diseases in Tunisia: Current Situation and Main Milestones Achieved.

Authors:  Nessrine Mezzi; Olfa Messaoud; Rahma Mkaouar; Nadia Zitouna; Safa Romdhane; Ghaith Abdessalem; Cherine Charfeddine; Faouzi Maazoul; Ines Ouerteni; Yosr Hamdi; Anissa Zaouak; Ridha Mrad; Sonia Abdelhak; Lilia Romdhane
Journal:  Genes (Basel)       Date:  2021-11-19       Impact factor: 4.096

3.  Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.

Authors:  Jin-Yue Li; Xiao-Han Sun; Dong-Chao Shen; Xun-Zhe Yang; Ming-Sheng Liu; Li-Ying Cui
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.